Ador Multi Products Ltd
Ador Multi Products is engaged in a Toiletries preparation & Cosmetics organisation that operates on the Manufacturing of cosmetics with its clients in recommending.(Source : 201903 Annual Report Page No: 49)
- Market Cap ₹ 31.3 Cr.
- Current Price ₹ 66.9
- High / Low ₹ 103 / 47.2
- Stock P/E
- Book Value ₹ 36.2
- Dividend Yield 0.00 %
- ROCE -34.8 %
- ROE -40.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Debtor days have improved from 57.0 to 43.7 days.
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 38.6%
- Company has a low return on equity of -32.6% over last 3 years.
- Company's cost of borrowing seems high
- Working capital days have increased from 9.47 days to 90.2 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|
5.80 | 6.69 | 6.57 | 7.28 | 9.87 | 19.34 | 13.44 | 13.55 | |
6.76 | 8.02 | 7.35 | 8.56 | 12.96 | 20.42 | 19.81 | 20.69 | |
Operating Profit | -0.96 | -1.33 | -0.78 | -1.28 | -3.09 | -1.08 | -6.37 | -7.14 |
OPM % | -16.55% | -19.88% | -11.87% | -17.58% | -31.31% | -5.58% | -47.40% | -52.69% |
0.14 | 2.27 | 0.16 | 0.18 | 0.54 | 4.27 | 0.30 | 0.31 | |
Interest | 0.32 | 0.34 | 0.20 | 0.07 | 0.38 | 0.29 | 0.31 | 0.38 |
Depreciation | 0.18 | 0.09 | 0.12 | 0.20 | 0.26 | 0.36 | 0.43 | 0.53 |
Profit before tax | -1.32 | 0.51 | -0.94 | -1.37 | -3.19 | 2.54 | -6.81 | -7.74 |
Tax % | 34.09% | 45.10% | -3.19% | 0.73% | 10.66% | 40.94% | -1.91% | |
Net Profit | -0.88 | 0.28 | -0.97 | -1.36 | -2.85 | 1.50 | -6.93 | -7.87 |
EPS in Rs | -3.07 | 0.98 | -3.39 | -3.62 | -7.19 | 3.21 | -14.83 | -16.83 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 23% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -41% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 28% |
3 Years: | 36% |
1 Year: | -21% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -31% |
3 Years: | -33% |
Last Year: | -41% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|
2.86 | 2.86 | 2.86 | 3.76 | 3.96 | 4.67 | 4.67 | 4.67 | |
Reserves | -0.49 | 2.54 | 0.94 | 1.74 | 3.87 | 8.79 | 16.07 | 12.23 |
2.32 | 2.57 | 0.50 | 0.59 | 4.23 | 2.58 | 0.61 | 0.09 | |
1.48 | 2.01 | 1.93 | 2.65 | 4.84 | 2.89 | 2.46 | 3.07 | |
Total Liabilities | 6.17 | 9.98 | 6.23 | 8.74 | 16.90 | 18.93 | 23.81 | 20.06 |
1.15 | 5.34 | 1.29 | 2.20 | 6.77 | 7.69 | 8.74 | 8.51 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.26 | 1.37 | 1.40 | 3.00 | 0.13 | 0.86 | 0.61 | 0.61 |
4.76 | 3.27 | 3.54 | 3.54 | 10.00 | 10.38 | 14.46 | 10.94 | |
Total Assets | 6.17 | 9.98 | 6.23 | 8.74 | 16.90 | 18.93 | 23.81 | 20.06 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|
0.00 | 9.43 | -3.52 | -0.56 | -3.68 | -7.06 | -8.62 | |
0.00 | -3.17 | 3.63 | -2.89 | 3.18 | 4.19 | -0.90 | |
0.00 | 0.03 | 0.05 | 3.45 | 1.09 | 2.69 | 12.91 | |
Net Cash Flow | 0.00 | 6.29 | 0.16 | -0.01 | 0.59 | -0.18 | 3.40 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|
Debtor Days | 67.97 | 64.38 | 87.22 | 65.68 | 91.71 | 35.48 | 43.72 |
Inventory Days | 107.30 | 102.89 | 68.10 | 82.64 | 197.54 | 136.34 | 204.03 |
Days Payable | 89.71 | 82.47 | 66.57 | 95.04 | 184.51 | 86.86 | 179.32 |
Cash Conversion Cycle | 85.56 | 84.79 | 88.75 | 53.28 | 104.75 | 84.95 | 68.43 |
Working Capital Days | 67.97 | -79.66 | 59.44 | 17.05 | -80.62 | 18.87 | 90.16 |
ROCE % | -19.75% | -12.55% | -25.02% | -30.96% | -8.04% | -34.77% |
Documents
Announcements
- Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 31St December, 2022 25 Jan
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 4 Jan
- Closure of Trading Window 30 Dec 2022
- Financial Results For The Quarter And Half Year Ended 30Th September, 2022 4 Nov 2022
- Board Meeting Outcome for Outcome Of BM Held On 04Th November, 2022 4 Nov 2022
Annual reports
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Transition in Business model [1]
The company has transitioned to focus from a legacy business to focus on contract manufacturing and pioneering skincare in India, especially in the clean-beauty space.